Shaheryar Shafi

Dr. Shaheryar Shafi

Suzhou Institute of Biomedical Engineering and Technology, Suzhou, Anhui, China
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in Nature Immunology
Verified
Journal Article
Open access
PDF file
RZRongchuan Zhao
Rongchuan Zhao
JYJiao Yang
Jiao Yang
YZYunjiao Zhai
Yunjiao Zhai
HZHong Zhang
Hong Zhang
YZYuanshuai Zhou
Yuanshuai Zhou
MSminxuan sun
minxuan sun
Nucleophosmin 1 (NPM1) is commonly mutated in myelodysplastic syndrome (MDS) and acute myeloid leukemia. Concurrent inflammatory bowel diseases (IBD) and MDS are common, indicating a close relationship between IBD and MDS. Here we examined the function of NPM1 in IBD and colitis-associated colorectal cancer (CAC). NPM1 expression was reduced in patients with IBD. Npm1 +/− mice were more susceptible to acute colitis and experimentally induced CAC than littermate controls. Npm1 deficiency impaired the function of interleukin-22 (IL-22)-producing group three innate lymphoid cells (ILC3s). Mice lacking Npm1 in ILC3s exhibited decreased IL-22 production and accelerated development of colitis. NPM1 was important for mitochondrial biogenesis and metabolism by oxidative phosphorylation in ILC3s. Further experiments revealed that NPM1 cooperates with p65 to promote mitochondrial transcription factor A (TFAM) transcription in ILC3s. Overexpression of Npm1 in mice enhanced ILC3 function and reduced the severity of dextran sulfate sodium-induced colitis. Thus, our findings indicate that NPM1 in ILC3s protects against IBD by regulating mitochondrial metabolism through a p65-TFAM axis.

17 August 2022 in Polymer Testing
Verified
Journal Article
Open access
NONan Ouyang
Nan Ouyang
LHLei Hong
Lei Hong
YZYuanshuai Zhou
Yuanshuai Zhou
JZJingzhong Zhang
Jingzhong Zhang
Shaheryar ShafiShaheryar Shafi
Shaheryar Shafi
WHWenya Hou
Wenya Hou
1

1 January 2023 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
LSLinjuan Sun
Linjuan Sun
NONan Ouyang
Nan Ouyang
Shaheryar ShafiShaheryar Shafi
Shaheryar Shafi
RZRongchuan Zhao
Rongchuan Zhao
JPJinlin Pan
Jinlin Pan
YZyuanshuai Zhou
yuanshuai Zhou
Introduction: Nuclear respiratory factor 1 (NRF1) is an important regulator involved in mitochondrial biogenesis and energy metabolism. However, the specific mechanism of NRF1 in anoikis and epithelial-mesenchymal transition (EMT) remains unclear. Methods: We examined the effect of NRF1 on mitochondria and identified the specific mechanism through transcriptome sequencing, and explored the relationships among NRF1, anoikis, and EMT. Results: We found that upregulated NRF1 expression led to increased mitochondrial oxidative phosphorylation (OXPHOS) and ATP generation. Simultaneously, a significant amount of ROS is generated during OXPHOS. Alternatively, NRF1 upregulates the expression of ROS-scavenging enzymes, allowing tumor cells to maintain low ROS levels and promoting anoikis resistance and EMT. We also found that exogenous ROS was maintained at a low level by NRF1 in breast cancer cells. Conclusion: our study provides mechanistic insight into the function of NRF1 in breast cancer, indicating that NRF1 may serve as a therapeutic target for breast cancer treatment.

16 August 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
MLMengyang Lu
Mengyang Lu
YZYuanshuai Zhou
Yuanshuai Zhou
LSLinjuan Sun
Linjuan Sun
Shaheryar ShafiShaheryar Shafi
Shaheryar Shafi
NANafees Ahmad
Nafees Ahmad
JDJun Dong
Jun Dong
Ferroptosis is one of the programmed modes of cell death that has attracted widespread attention recently and is capable of influencing the developmental course and prognosis of many tumors. Glioma is one of the most common primary tumors of the central nervous system, but effective treatment options are very limited. Ferroptosis plays a critical role in the glioma progression, affecting tumor cell proliferation, angiogenesis, tumor necrosis, and shaping the immune-resistant tumor microenvironment. Inducing ferroptosis has emerged as an attractive strategy for glioma. In this paper, we review ferroptosis-related researches on glioma progression and treatment.
1

30 December 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
YZYu Zhao
Yu Zhao
XZXinying Zhou
Xinying Zhou
LHLei Hong
Lei Hong
JYJinyu Yao
Jinyu Yao
JPJinlin Pan
Jinlin Pan
MSminxuan sun
minxuan sun

21 March 2024 in Journal of Cancer Metastasis and Treatment
Verified
Journal Article
Open access
PDF file
XZXinying Zhou
Xinying Zhou
YZYu Zhao
Yu Zhao
RZRongchuan Zhao
Rongchuan Zhao
Shaheryar ShafiShaheryar Shafi
Shaheryar Shafi
YYYue Yang
Yue Yang
SLSongbai Liu
Songbai Liu
Colorectal cancer (CRC) is one of the most common malignancies of the digestive tract, with increasing morbidity and mortality worldwide, and is the third most common malignancy in the world. At present, the main treatment methods for CRC include surgery, chemotherapy, targeted therapy, and immunotherapy. Regulation of the gut microbiota is one of the most promising new strategies for CRC treatment. Gut microbiota interacts with host cells to regulate many physiological processes, such as energy acquisition, metabolism, and immune responses. Recent studies have found that a combination of gut microbiota with targeted therapy and immunotherapy could improve the therapeutic effect of colon cancer compared with treatment alone. This article reviews the mechanism of microbiota regulation in CRC and the latest progress of intestinal microbiota in targeted therapy and immunotherapy of CRC, which is helpful in developing potential prevention or treatment strategies for colorectal cancer.